Results 171 to 180 of about 89,135 (337)

Metabolic bariatric surgery is associated with reduced adverse hepatic and extrahepatic outcomes, and lower all‐cause mortality, in patients with steatotic liver disease

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 174-185, January 2026.
Abstract Aim Metabolic bariatric surgery (MBS) improves histological endpoints in steatotic liver disease (SLD), but data on longer‐term clinical outcomes in this population are scarce. Here, we assessed the impact of MBS on hepatic and extrahepatic morbidity and mortality in individuals with SLD.
Weronika Stupalkowska   +4 more
wiley   +1 more source

Medical events and costs associated with metabolic bariatric surgery among adults with type 2 diabetes: A retrospective, matched cohort study

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 529-538, January 2026.
Abstract Aims This study examined rates of metabolic/bariatric surgery (MBS) among adults with type 2 diabetes and obesity (T2D + O). The study also compared glucose‐lowering medication (GLM) use, costs, comorbidities and medical events for individuals with T2D + O who underwent MBS (cases) to those who did not have MBS (controls).
Kristina S. Boye   +4 more
wiley   +1 more source

Laparoscopic surgery for gallbladder cancer: is skepticism still justified? [PDF]

open access: yesHepatobiliary Surg Nutr
Ielpo B   +5 more
europepmc   +1 more source

Oleanolic acid induces mitochondrial-dependent apoptosis and G0/G1 phase arrest in gallbladder cancer cells

open access: gold, 2015
Huai-Feng Li   +15 more
openalex   +2 more sources

Therapeutic Potential of Melatonin in Gastrointestinal Cancers: Molecular Mechanisms, Preclinical Evidence and Clinical Implications

open access: yesJournal of Pineal Research, Volume 78, Issue 1, January 2026.
ABSTRACT Gastrointestinal (GI) cancers remain a leading cause of global morbidity and mortality, necessitating novel therapeutic strategies. Melatonin (MEL), an indoleamine with pleiotropic biological activities, has emerged as a promising adjuvant in oncology due to its antiproliferative, proapoptotic, and antioxidant properties.
Maciej Gonciarz   +4 more
wiley   +1 more source

Gallbladder Cancer Concomitant With Para-Aortic Paraganglioma: A Case Report. [PDF]

open access: yesClin Case Rep
Murakami H   +8 more
europepmc   +1 more source

Response of BRCA1-mutated gallbladder cancer to olaparib: A case report

open access: hybrid, 2016
Yuan Xie   +11 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy